File Download
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.26508/lsa.202000640
- Scopus: eid_2-s2.0-85087015158
- PMID: 32576602
- WOS: WOS:000564798900001
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: EBV renders B cells susceptible to HIV-1 in humanized mice
Title | EBV renders B cells susceptible to HIV-1 in humanized mice |
---|---|
Authors | McHugh, DMyburgh, RCaduff, NSpohn, MKok, YLKeller, CWMurer, AChatterjee, BRühl, JEngelmann, CChijioke, OQuast, IShilaih, MStrouvelle, VPNeumann, KMenter, TDirnhofer, SLam, JKPHui, KFBredl, SSchlaepfer, ESorce, SZbinden, ACapaul, RLünemann, JDAguzzi, AChiang, AKSKempf, WTrkola, AMetzner, KJManz, MGGrundhoff, ASpeck, RFMünz, C |
Issue Date | 2020 |
Publisher | Life Science Alliance LLC. The Journal's web site is located at https://www.life-science-alliance.org/ |
Citation | Life Science Alliance, 2020, v. 3 n. 8, p. article no. e202000640 How to Cite? |
Abstract | HIV and EBV are human pathogens that cause a considerable burden to worldwide health. In combination, these viruses are linked to AIDS-associated lymphomas. We found that EBV, which transforms B cells, renders them susceptible to HIV-1 infection in a CXCR4 and CD4-dependent manner in vitro and that CXCR4-tropic HIV-1 integrates into the genome of these B cells with the same molecular profile as in autologous CD4+ T cells. In addition, we established a humanized mouse model to investigate the in vivo interactions of EBV and HIV-1 upon coinfection. The respective mice that reconstitute human immune system components upon transplantation with CD34+ human hematopoietic progenitor cells could recapitulate aspects of EBV and HIV immunobiology observed in dual-infected patients. Upon coinfection of humanized mice, EBV/HIV dual-infected B cells could be detected, but were susceptible to CD8+ T-cell–mediated immune control. |
Persistent Identifier | http://hdl.handle.net/10722/290627 |
ISSN | 2023 Impact Factor: 3.3 2023 SCImago Journal Rankings: 1.907 |
PubMed Central ID | |
ISI Accession Number ID |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | McHugh, D | - |
dc.contributor.author | Myburgh, R | - |
dc.contributor.author | Caduff, N | - |
dc.contributor.author | Spohn, M | - |
dc.contributor.author | Kok, YL | - |
dc.contributor.author | Keller, CW | - |
dc.contributor.author | Murer, A | - |
dc.contributor.author | Chatterjee, B | - |
dc.contributor.author | Rühl, J | - |
dc.contributor.author | Engelmann, C | - |
dc.contributor.author | Chijioke, O | - |
dc.contributor.author | Quast, I | - |
dc.contributor.author | Shilaih, M | - |
dc.contributor.author | Strouvelle, VP | - |
dc.contributor.author | Neumann, K | - |
dc.contributor.author | Menter, T | - |
dc.contributor.author | Dirnhofer, S | - |
dc.contributor.author | Lam, JKP | - |
dc.contributor.author | Hui, KF | - |
dc.contributor.author | Bredl, S | - |
dc.contributor.author | Schlaepfer, E | - |
dc.contributor.author | Sorce, S | - |
dc.contributor.author | Zbinden, A | - |
dc.contributor.author | Capaul, R | - |
dc.contributor.author | Lünemann, JD | - |
dc.contributor.author | Aguzzi, A | - |
dc.contributor.author | Chiang, AKS | - |
dc.contributor.author | Kempf, W | - |
dc.contributor.author | Trkola, A | - |
dc.contributor.author | Metzner, KJ | - |
dc.contributor.author | Manz, MG | - |
dc.contributor.author | Grundhoff, A | - |
dc.contributor.author | Speck, RF | - |
dc.contributor.author | Münz, C | - |
dc.date.accessioned | 2020-11-02T05:44:53Z | - |
dc.date.available | 2020-11-02T05:44:53Z | - |
dc.date.issued | 2020 | - |
dc.identifier.citation | Life Science Alliance, 2020, v. 3 n. 8, p. article no. e202000640 | - |
dc.identifier.issn | 2575-1077 | - |
dc.identifier.uri | http://hdl.handle.net/10722/290627 | - |
dc.description.abstract | HIV and EBV are human pathogens that cause a considerable burden to worldwide health. In combination, these viruses are linked to AIDS-associated lymphomas. We found that EBV, which transforms B cells, renders them susceptible to HIV-1 infection in a CXCR4 and CD4-dependent manner in vitro and that CXCR4-tropic HIV-1 integrates into the genome of these B cells with the same molecular profile as in autologous CD4+ T cells. In addition, we established a humanized mouse model to investigate the in vivo interactions of EBV and HIV-1 upon coinfection. The respective mice that reconstitute human immune system components upon transplantation with CD34+ human hematopoietic progenitor cells could recapitulate aspects of EBV and HIV immunobiology observed in dual-infected patients. Upon coinfection of humanized mice, EBV/HIV dual-infected B cells could be detected, but were susceptible to CD8+ T-cell–mediated immune control. | - |
dc.language | eng | - |
dc.publisher | Life Science Alliance LLC. The Journal's web site is located at https://www.life-science-alliance.org/ | - |
dc.relation.ispartof | Life Science Alliance | - |
dc.rights | This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. | - |
dc.title | EBV renders B cells susceptible to HIV-1 in humanized mice | - |
dc.type | Article | - |
dc.identifier.email | Chiang, AKS: chiangak@hku.hk | - |
dc.identifier.authority | Chiang, AKS=rp00403 | - |
dc.description.nature | published_or_final_version | - |
dc.identifier.doi | 10.26508/lsa.202000640 | - |
dc.identifier.pmid | 32576602 | - |
dc.identifier.pmcid | PMC7335381 | - |
dc.identifier.scopus | eid_2-s2.0-85087015158 | - |
dc.identifier.hkuros | 317754 | - |
dc.identifier.volume | 3 | - |
dc.identifier.issue | 8 | - |
dc.identifier.spage | article no. e202000640 | - |
dc.identifier.epage | article no. e202000640 | - |
dc.identifier.isi | WOS:000564798900001 | - |
dc.publisher.place | United States | - |
dc.identifier.issnl | 2575-1077 | - |